Skip to main content
. 2019 Feb 19;33(7):1060–1067. doi: 10.1038/s41433-019-0360-z

Table 1.

Baseline characteristics of the participants

Group P-value
Fluoxetine Placebo
Number, n 20 15
Gender, M / F, n 8/12 8/7 0.433
Age, years 21 ± 8 21 ± 7 0.895
Baseline VA, logMAR 0.490 ± 0.148 0.493 ± 0.138 0.946
Anisometropia, D 3.1 ± 1.3 2.8 ± 1.5 0.514

F female, M male, VA visual acuity, y year(s)